Neogen Corporation Long-Term Debt
Neogen Corporation (NEOG) had Long-Term Debt of $793.70 million as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-07-30
- 2026-05-31: Long-term Debt, Excluding Current Maturities $793.70M.
- 2026-02-28: Long-term Debt, Excluding Current Maturities $793.30M.
- 2025-11-30: Long-term Debt, Excluding Current Maturities $792.93M.
- 2025-08-31: Long-term Debt, Excluding Current Maturities $792.53M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-05-31 | $793.70M 10-K · filed 2026-07-30 | |
| 2026-02-28 | $793.30M 10-Q · filed 2026-04-09 | |
| 2025-11-30 | $792.93M 10-Q · filed 2026-01-08 | |
| 2025-08-31 | $792.53M 10-Q · filed 2025-10-09 | |
| 2025-05-31 | $874.80M 10-K · filed 2026-07-30 | $874.81M 10-K · filed 2025-07-30 |
| 2025-02-28 | $890.61M 10-Q · filed 2025-04-09 | |
| 2024-11-30 | $889.87M 10-Q · filed 2025-01-15 | |
| 2024-08-31 | $889.13M 10-Q · filed 2024-10-10 | |
| 2024-05-31 | $888.39M 10-K · filed 2025-07-30 | |
| 2024-02-29 | $887.65M 10-Q · filed 2024-04-09 | |
| 2023-11-30 | $886.91M 10-Q · filed 2024-01-09 | |
| 2023-08-31 | $886.18M 10-Q · filed 2023-10-10 | |
| 2023-05-31 | $885.44M 10-K · filed 2024-07-30 | |
| 2023-02-28 | $884.70M 10-Q · filed 2023-04-04 | |
| 2022-11-30 | $923.96M 10-Q · filed 2023-01-09 | |
| 2022-05-31 | $0.00 10-Q · filed 2023-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |